FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms

FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms is a pharma and life sciences industry update from FDA Press Releases. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

FDA · 2026-08-05

The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.

Source: FDA Press Releases